spacer
home > ebr > summer 2003 > managing your way out of the success trap
PUBLICATIONS
European Biopharmaceutical Review

Managing your Way Out of the Success Trap

Pharmaceutical companies are facing a new kind of challenge: breakthrough biotech products that are so successful they overwhelm manufacturing capacity. With biological manufacturing set-up costs in the hundreds of millions of dollars per product, it is a tough call to predict market success correctly. Aiming too high in capacity means that costs may never be recovered. On the other hand, with set-up times for new facilities often extending to three or four years, planning capacity too low can mean years of short supply.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Geoff Tomlinson, Principal, and Hannes Kunz, Director of PRTM

Geoff Tomlinson is a Principal in the Life Sciences Practice of global management consultants PRTM. His consulting experience includes work with companies across Europe and the US on supply chain management, marketing and sales initiatives. These engagements have covered a range of industries including pharmaceutical, medical devices and diagnostics, and consumer goods.

Prior to consulting, Geoff worked in management positions for Rank Hovis McDougall in sales, production and quality. He holds a degree in Biological Sciences from Exeter University and has an MBA from Manchester Business School.


Hannes Kunz is a Director in the Life Sciences Practice of global management consultants PRTM. Hannes has led numerous projects with companies across a range of industry sectors, including life sciences. He has extensive experience in facilitating emerging and global companies to deliver value to their customers through their product strategies and product development excellence, e-business, marketing and CRM.

Prior to joining PRTM, Hannes was a Director at a consulting firm with the responsibility for customer relationship management, e-commerce consulting and implementation services for German-speaking countries. Hannes holds degrees in both Law and Economics from the University of Zurich.


spacer
Geoff Tomlinson
spacer
spacer
spacer
Hannes Kunz
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor

Eppendorf

The number of bioprocess applications for microalgae has increased in recent years, particularly in the fi eld of biofuel production. The combination of the New Brunswick CelliGen 310 stirred-tank bioreactor and the DASGIP LED Illumination System creates a bioreactor setup which is capable of supporting high density microalgal growth. Using the stand-alone Eppendorf DASGIP PBR4 Module, LED illumination spectra and intensities can be controlled for optimal support of all types of chlorophylls and carotenoids. For this study in which high density culture of up to 1.5 x 107 cells/mL was achieved, the unicellular freshwater alga, Dunaliella tertiolecta, was used.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement